文献速递类风湿关节炎其他结缔组织病

甲氨蝶呤与间质性肺病:争议与问题的叙述性综述

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

本文综述了观察性研究和临床试验中关于甲氨蝶呤(MTX)治疗类风湿关节炎(RA)患者肺部疾病的证据。文章聚焦讨论MTX相关肺炎(M-pneu)与RA自然病程中出现的间质性肺病(RA-ILD)之间缺乏关联,并指出尽管M-pneu报告频率为0.3-11.6%,但近期研究和荟萃分析提示其实际发生率可能更低。

要点

  • M-pneu通常为超敏反应,多在MTX启用后早期发生且呈剂量非依赖性。
  • M-pneu与RA-ILD似乎并无真正关联,后者是RA自然病史的一部分。
  • 对已有肺部疾病者启用MTX需谨慎,但进行性RA不应因此延迟或限制MTX治疗。

核心结论

  • M-pneu与RA-ILD之间缺乏关联,MTX仍是达标治疗的核心药物之一。

研究设计与样本

  • 叙述性综述,汇总观察性研究与临床试验中MTX治疗RA患者肺部疾病的证据。

主要发现

  • M-pneu报告频率范围为0.3-11.6%,但近期研究和荟萃分析提示其发生率低于既往认为。
  • M-pneu被视为超敏反应,通常发生在MTX启用后早期,且呈剂量非依赖性。
  • M-pneu似乎与部分RA患者自然病程中出现的RA-ILD无真正关联。
  • 有数据提示对已有肺部疾病者启用MTX应谨慎。

关键数值与推荐

  • M-pneu报告频率为0.3-11.6%。

临床怎么用

  • 对已有肺部疾病者启用MTX需谨慎评估。
  • 进行性RA可能进展为RA-ILD,不应因此延迟或限制MTX治疗。
  • MTX仍是达标治疗策略中的核心药物之一。

局限性

  • 本文为叙述性综述,未报告系统检索策略或定量合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

MTX, which is the anchor-drug for the treatment of RA, has been associated with lung injury and in particular with MTX-related pneumonitis (M-pneu). Although the frequency of M-pneu has been reported to range between 0.3 and 11.6%, more recent studies and meta-analyses have challenged that, suggesting that it is less common than previously thought. M-pneu is considered a hypersensitivity reaction usually occuring early after MTX commencement, and to be dose-independent. Furthermore, it does not seem to be truly related to the development of interstitial lung disease observed in some patients as part of the natural history of RA (RA-ILD). On the other hand, there are data suggesting that clinicians should be cautious when commencing MTX in patients with pre-existing lung disease. However, treatment should not be delayed or limited in progressive RA that could lead to RA-ILD, and MTX remains one of the central players in the treat-to-target approach. In this review, we aimed to summarize the current evidence from observational studies and clinical trials on lung disease in MTX-treated RA patients. We focus the discussion on the lack of association between M-pneu and RA-ILD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fragoulis GE, Conway R, Nikiphorou E, et al. Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature. Rheumatology (Oxford). 2019. PMID: 31504978. doi:10.1093/rheumatology/kez337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。